...
机译:抗复苏药物临床试验的骨质周转和骨折风险的相关变化:荟萃回归
Departments of Medicine and Epidemiology &
BiostatisticsUniversity of California San FranciscoSan;
Departments of Medicine and Epidemiology &
BiostatisticsUniversity of California San FranciscoSan;
Center for Advanced Orthopedic StudiesBeth Israel Deaconess Medical Center and Harvard Medical;
California Pacific Medical CenterSan Francisco CA USA;
Department of EpidemiologyUniversity of PittsburghPittsburgh PA USA;
Merck &
Co. Inc.Kenilworth NJ USA;
Amgen Inc.Thousand Oaks CA USA;
Mayo Clinic Center for Clinical and Translational ScienceRochester MN USA;
Departments of Medicine and Epidemiology &
BiostatisticsUniversity of California San FranciscoSan;
Academic Unit of Bone MetabolismUniversity of SheffieldSheffield UK;
BIOCHEMICAL MARKERS OF BONE TURNOVER; BONE MODELING AND REMODELING; EPIDEMIOLOGY; OSTEOPOROSIS; DISEASES AND DISORDERS OF/RELATED TO BONE;
机译:抗复苏药物临床试验的骨质周转和骨折风险的相关变化:荟萃回归
机译:回复:骨密度的变化和裂缝风险的降低:发表试验的荟萃回归
机译:骨密度的变化和骨折风险的降低:发表试验的荟萃回归
机译:减少抗吸收药物治疗后的吸收腔大小
机译:使用二项式回归和二叉分类树比较一项针对消化不良的不同药物治疗的临床试验数据进行的分析
机译:常规抗骨质疏松药物治疗是否可以降低男性受试者发生骨折的风险?对临床试验进行荟萃分析的最新系统评价
机译:骨质周转和骨折风险抗复苏药物临床试验的治疗相关变化:荟萃回归